9006:TSEKeikyu Corporation Analysis
Data as of 2026-06-17 - not real-time
¥1,463.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The share price is trading below its short‑ and medium‑term averages, while the RSI sits in the neutral‑to‑slightly‑bearish zone. A modestly positive MACD histogram suggests a tentative bullish tilt, and the price remains comfortably above the identified support level. Volatility is elevated, yet the beta is low, indicating limited systematic risk.
Fundamental backdrop: Revenue is expanding at a healthy pace and the company commands a dividend yield that outperforms many peers, with a payout ratio that appears sustainable for now. Valuation metrics such as the P/E are markedly cheaper than the industry average, but the DCF model flags a substantial gap between intrinsic and market values. The balance sheet is heavily levered, free cash flow is negative, and earnings forecasts point to a downward revision, all of which dampen the upside narrative.
Investment implication: While the dividend and relative valuation offer some appeal, the combination of high debt, cash‑flow constraints, and a DCF‑derived overvaluation tilts the overall view toward caution. The market sentiment is currently in an “extreme greed” phase, which may be pricing in optimism beyond fundamentals. Investors should weigh the dividend income against the leverage risk and consider a measured stance.
Fundamental backdrop: Revenue is expanding at a healthy pace and the company commands a dividend yield that outperforms many peers, with a payout ratio that appears sustainable for now. Valuation metrics such as the P/E are markedly cheaper than the industry average, but the DCF model flags a substantial gap between intrinsic and market values. The balance sheet is heavily levered, free cash flow is negative, and earnings forecasts point to a downward revision, all of which dampen the upside narrative.
Investment implication: While the dividend and relative valuation offer some appeal, the combination of high debt, cash‑flow constraints, and a DCF‑derived overvaluation tilts the overall view toward caution. The market sentiment is currently in an “extreme greed” phase, which may be pricing in optimism beyond fundamentals. Investors should weigh the dividend income against the leverage risk and consider a measured stance.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Positive MACD momentum
- Price above key support
- Attractive dividend yield
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation gap between market price and DCF
- High leverage and negative free cash flow
- Earnings outlook trending lower
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustainable dividend payout
- Low systematic (beta) risk
- Sector stability offset by balance‑sheet concerns
Key Metrics & Analysis
Financial Health
Revenue Growth7.20%
Profit Margin9.04%
P/E Ratio14.4
ROE7.22%
ROA1.93%
Debt/Equity130.97
P/B Ratio1.0
Op. Cash Flow¥47.9B
Free Cash Flow¥-51999997952
Industry P/E31.2
Technical Analysis
TrendNeutral
RSI41.5
Support¥1,441.50
Resistance¥1,583.50
MA 20¥1,487.13
MA 50¥1,534.46
MA 200¥1,526.34
MACDBullish
VolumeStable
Fear & Greed Index88.5
Valuation
Fair Value¥603.61
Target Price¥1,542.50
Upside/Downside5.43%
GradeOvervalued
TypeBlend
Dividend Yield3.13%
Risk Assessment
Beta0.26
Volatility25.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.